In Silico Medicine

Researching next-generation life sciences innovations in the UK, in partnership with KTN

UK SMEs are using ‘in silico’ technologies to support a range of exciting outcomes in the life sciences and medical technology sectors. These include improving and accelerating our ability to tackle disease and health problems with more effective treatments, drugs and medical devices. 

In silico refers to the use of computer modelling and simulation to undertake virtual experiments. 

Over the last decade, in silico SMEs in the UK have received a total of £860m worth of equity investment. Most funding rounds have been secured by companies at the venture or seed stage, reflecting the relative youth of the sector.

This investment, alongside university and corporate support, is key to the ongoing development of in silico technologies, and the UK is well placed to become a global leader in this space.

Click here to read our analysis of the UK’s private in silico sector, including demographic data and investment trends.

Inside the report…

In Silico Medicine report - introducing in silico medicine
In Silico Medicine report - investment opportunities

About the authors

henry whorwood

Henry leads our Research & Consultancy team, and is an expert on equity finance and high-growth business. He's worked on briefs for the likes of Barclays, SyndicateRoom, Innovate UK, Smith & Williamson and British Business Bank. He regularly gives presentations on market trends at events around the UK.

Dan_website-scaled.jpg

Daniel robinson

Daniel conducts data manipulation and analysis as part of the Research & Consultancy team. He has a background in business analysis and commercial copywriting in Australia and the UK, having worked at The Sunday Times Fast Track, Oxford University Press, and advertising network MullenLowe Group.

Freya Hyde

Freya performs data analysis and visualisation in the Research & Consultancy team, with a focus on design. She has worked on projects for clients including Barclays, EY and JP Morgan. Freya holds a BA in History (International) from the University of Leeds, which included a year at Fudan University in Shanghai.

Advone Katsande

Advone Katsande

Advone writes copy, and performs data analysis and visualisation. She has written on the nature of Venture Capital Trusts, and worked on projects for Rawnet and Deloitte. She read Law at the University of East Anglia, where she acquired her undergraduate LLB.

Ethan Yip

Ethan carries out data analysis and visualisation. Before joining Beauhurst, Ethan graduated from the University of Bath, where he was awarded the degree of Master of Chemistry (MChem) and spent a year studying at the National University of Singapore.

More leads, more clients, less churn.

Get access to unrivalled data on all the companies you need to know about, so you can approach the right leads, at the right time.

Book a 40 minute demo today to see all of the key features, as well as the depth and breadth of data available on the Beauhurst platform.

An associate will work with you to build a sophisticated search, returning a dynamic list of organisations matching your ideal client profile.

“It’s taken us an eternity to find the same companies that Beauhurst listed in just minutes!”

Sign up today to get a free demo where you can access the platform.

We’ll help you navigate the platform, so you can:

Everything will be customised around your business and needs, so you can explore relevant data and get the most out of the platform.

Did you know? Beauhurst is the only provider of unannounced fundraisings data—which account for 70% of all fundraisings. Don’t miss out! Sign up now.

Enter your info now to try Beauhurst:

Beauhurst is a single source of truth on the UK’s high-growth economy – it truly is our guiding light in finding the right businesses to approach.

Propel.svg
BGF.svg
BGF.svg